Parisa Farokh

1PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Dec 05, 2024
The efficacy and safety of relatlimab/nivolumab combination therapy in patients with advanced melanoma: a systematic review.

Saba Hasanzadeh, Parisa Farokh, Fatemeh Vazifeh

Pageof 1

Frequent Collaborators

1 joint publications

Saba Hasanzadeh

1 joint publications

Fatemeh Vazifeh

1 joint publications

Golsa Sadat Hosseini

1 joint publications

Leila Rezaei

1 joint publications

Mozhgan Ghaedrahmati

1 joint publications

Zahra Razaghi

1 joint publications

Mostafa Rezaei Tavirani

1 joint publications

Reza M Robati

Frequent Collaborators

1 joint publications

Saba Hasanzadeh

1 joint publications

Fatemeh Vazifeh

1 joint publications

Golsa Sadat Hosseini

1 joint publications

Leila Rezaei

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

3.3K
See more related videos

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

3.3K
See more related videos